These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6521151)

  • 21. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
    Scott MT; Warner SL
    Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.
    Denny FW; Taylor-Robinson D; Allison AC
    J Med Microbiol; 1972 Aug; 5(3):327-36. PubMed ID: 4560750
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of inherited deficiency of the fifth component of complement on arthritis induced in mice by Mycoplasma pulmonis.
    Keystone E; Taylor-Robinson D; Pope C; Taylor G; Furr P
    Arthritis Rheum; 1978; 21(7):792-7. PubMed ID: 697951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nonspecific immunotherapy using 2,4,6-trimethylhydroxypyrimidine (OPM-111) in Mycoplasma arthritidis infection in mice].
    Rakovskaia IV; Beliaev DL; Suskova VS; Smirnov LD; Akhmedov EF
    Antibiot Med Biotekhnol; 1986 Dec; 31(12):914-7. PubMed ID: 3566221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of cancer with immunomodulators.
    Oettgen HF; Pinsky CM; Delmonte L
    Med Clin North Am; 1976 May; 60(3):511-37. PubMed ID: 1271891
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunology in cutaneous leishmaniasis.
    Preston PM
    Proc R Soc Med; 1973 Aug; 66(8):776-7. PubMed ID: 4200332
    [No Abstract]   [Full Text] [Related]  

  • 29. [Corynebacteria--stimulators of antitumor resistance].
    Zatula DG; Zaval'niuk AK; Tofan AV
    Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
    Taylor G; Howard CJ
    Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulating effect of neurotropin on delayed type hypersensitivity response in mice.
    Yoshii H; Matsuoka T; Kurimoto Y; Suehiro S
    Jpn J Pharmacol; 1988 Aug; 47(4):433-5. PubMed ID: 3184569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy: concepts and nursing implications.
    McCalla JL
    Nurs Clin North Am; 1976 Mar; 11(1):59-71. PubMed ID: 1083016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein.
    Scott MT; Bahr G; Moddaber F; Afchain D; Chedid L
    Int Arch Allergy Appl Immunol; 1984; 74(4):373-7. PubMed ID: 6429057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Klebsiella pneumoniae glycoprotein RU-41740 enhances resistance of mice against Mycoplasma arthritidis-induced arthritis.
    Kaklamani E; Koumantaki Y; Karalis D; Rommain M; Smets P; Kaklamanis P; Blackwell CC; Weir DM
    FEMS Microbiol Immunol; 1991 Aug; 3(4):205-10. PubMed ID: 1931133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.
    Karvonen SL; Räsänen L; Cunliffe WJ; Holland KT; Karvonen J; Reunala T
    Dermatology; 1994; 189(4):344-9. PubMed ID: 7873817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the bacillus of Calmette-Guérin, Propionibacter acnes and avridine as immunomodulators in antirabies vaccination of mice using the Fuenzalida-Palacios mouse brain vaccine.
    Megid J; Peraçolli MT; Curi PR; Zanetti CR; Cabrera WH; Vassao R; Ito FH
    Vaccine; 1999 May; 17(19):2446-52. PubMed ID: 10392627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of delayed-type hypersensitivity and graft-versus-host reaction in testing of immunomodulators.
    Sůla K
    Folia Biol (Praha); 1992; 38(1):31-9. PubMed ID: 1597252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen.
    Scott MT
    Cell Immunol; 1974 Aug; 13(2):251-63. PubMed ID: 4281350
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of pneumonia induced in mice with Mycoplasma pulmonis on resistance to subsequent bacterial infection and the effect of a respiratory infection with Sendai virus on the resistance of mice to Mycoplasma pulmonis.
    Howard CJ; Stott EJ; Taylor G
    J Gen Microbiol; 1978 Nov; 109(1):79-87. PubMed ID: 215702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.